These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 33962037)

  • 21. [Rheumatoid arthritis].
    To H
    Nihon Rinsho; 2013 Dec; 71(12):2141-5. PubMed ID: 24437269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nanotechnology as a promising platform for rheumatoid arthritis management: Diagnosis, treatment, and treatment monitoring.
    Rahimizadeh P; Rezaieyazdi Z; Behzadi F; Hajizade A; Lim SI
    Int J Pharm; 2021 Nov; 609():121137. PubMed ID: 34592396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Noble Metal Nanomaterials for NIR-Triggered Photothermal Therapy in Cancer.
    Lv Z; He S; Wang Y; Zhu X
    Adv Healthc Mater; 2021 Mar; 10(6):e2001806. PubMed ID: 33470542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specific therapy to regulate inflammation in rheumatoid arthritis: molecular aspects.
    García-Hernández MH; González-Amaro R; Portales-Pérez DP
    Immunotherapy; 2014; 6(5):623-36. PubMed ID: 24896630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of rheumatoid arthritis by phototherapy: advances and perspectives.
    Dong Y; Cao W; Cao J
    Nanoscale; 2021 Sep; 13(35):14591-14608. PubMed ID: 34473167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanomaterials-based photothermal therapy and its potentials in antibacterial treatment.
    Chen Y; Gao Y; Chen Y; Liu L; Mo A; Peng Q
    J Control Release; 2020 Dec; 328():251-262. PubMed ID: 32889053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pre-clinical phase of rheumatoid arthritis: From risk factors to prevention of arthritis.
    Petrovská N; Prajzlerová K; Vencovský J; Šenolt L; Filková M
    Autoimmun Rev; 2021 May; 20(5):102797. PubMed ID: 33746022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterising arthralgia in the preclinical phase of rheumatoid arthritis using MRI.
    van Steenbergen HW; van Nies JA; Huizinga TW; Bloem JL; Reijnierse M; van der Helm-van Mil AH
    Ann Rheum Dis; 2015 Jun; 74(6):1225-32. PubMed ID: 24718962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiology of rheumatoid arthritis: rheumatoid arthritis and mortality.
    Myasoedova E; Davis JM; Crowson CS; Gabriel SE
    Curr Rheumatol Rep; 2010 Oct; 12(5):379-85. PubMed ID: 20645137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overview of the application of inorganic nanomaterials in cancer photothermal therapy.
    Fernandes N; Rodrigues CF; Moreira AF; Correia IJ
    Biomater Sci; 2020 Jun; 8(11):2990-3020. PubMed ID: 32355937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonpharmacological interventions for rheumatoid arthritis.
    Shaw K; Zochling J; Winzenberg T
    Aust Fam Physician; 2007 Oct; 36(10):840-1. PubMed ID: 17925906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neutrophils-mediated bioinspired nanoagents for noninvasive monitoring of inflammatory recruitment dynamics and navigating phototherapy in rheumatoid arthritis.
    Yu H; Wu Y; Xu J; Wang Y; Cheng X; Zhang LW; Qin J; Wang Y
    Biomater Adv; 2024 Apr; 158():213764. PubMed ID: 38227991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Folate receptor-targeting semiconducting polymer dots hybrid mesoporous silica nanoparticles against rheumatoid arthritis through synergistic photothermal therapy, photodynamic therapy, and chemotherapy.
    Li X; Zhang S; Zhang X; Hou Y; Meng X; Li G; Xu F; Teng L; Qi Y; Sun F; Li Y
    Int J Pharm; 2021 Sep; 607():120947. PubMed ID: 34358541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell-Based Therapy and Genome Editing as Emerging Therapeutic Approaches to Treat Rheumatoid Arthritis.
    Chasov V; Ganeeva I; Zmievskaya E; Davletshin D; Gilyazova E; Valiullina A; Bulatov E
    Cells; 2024 Jul; 13(15):. PubMed ID: 39120313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunopathogenic Mechanisms and Novel Immune-Modulated Therapies in Rheumatoid Arthritis.
    Chen SJ; Lin GJ; Chen JW; Wang KC; Tien CH; Hu CF; Chang CN; Hsu WF; Fan HC; Sytwu HK
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30884802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advancement in contemporary diagnostic and therapeutic approaches for rheumatoid arthritis.
    Kumar LD; Karthik R; Gayathri N; Sivasudha T
    Biomed Pharmacother; 2016 Apr; 79():52-61. PubMed ID: 27044812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-22 and rheumatoid arthritis: emerging role in pathogenesis and therapy.
    Xie Q; Huang C; Li J
    Autoimmunity; 2015 Mar; 48(2):69-72. PubMed ID: 25483133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The genetic pathogenesis, diagnosis and therapeutic insight of rheumatoid arthritis.
    Zamanpoor M
    Clin Genet; 2019 May; 95(5):547-557. PubMed ID: 30578544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mesenchymal Stem/Stromal Cells for Rheumatoid Arthritis Treatment: An Update on Clinical Applications.
    Lopez-Santalla M; Fernandez-Perez R; Garin MI
    Cells; 2020 Aug; 9(8):. PubMed ID: 32784608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical quality management in rheumatoid arthritis: putting theory into practice. Swiss Clinical Quality Management in Rheumatoid Arthritis.
    Uitz E; Fransen J; Langenegger T; Stucki G
    Rheumatology (Oxford); 2000 May; 39(5):542-9. PubMed ID: 10852987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.